Basic Info.
Name: Myo
Test Time: 15 Min
Temperature: 2-8ºC
Transport Package : Foam box
Specimen : Serum/Plasma
Production Capacity: 10000/Week
Applicable Device : CLite-160i/SMART 500H
Shelf life : 12 months
Specification: 30/60 tests/box (CLite-160i)
50/100 tests/box (SMART 500H)
Product Description:
Myoglobin (Myo), with a molecular weight of 17.8kD, consists of a polypeptide chain and a ferrous heme cogroup. Myo exists in human skeletal muscle and cardiomyocytes and has the function of carrying oxygen for cell respiration. In the early stage of acute myocardial infarction (AMI), Myo has a small molecular weight and can be rapidly released from damaged cells. Serum Myo concentration increases rapidly after 1 ~ 3h and reaches a peak after 6 ~ 7h. Myo levels in almost all patients with AMI increase within 12h, and the increase is greater than that of myocardial enzymes, so it can be used as an early diagnostic marker for AMI.
The clinical significance
Myoglobin (Myo), with a molecular weight of 17.8kD, is composed of a polypeptide chain and a heme cofactor. Myo is present in human skeletal muscle and myocardial cells and carries oxygen for cellular respiration.In the early stage of acute myocardial infarction (AMI), Myo has a small molecular weight and can be rapidly released from the damaged cells. The concentration of Myo in serum rises rapidly after 1 ~ 3h and reaches the peak at 6 ~ 7h. Within 12h, Myo in almost all patients with AMI increases, and the increase is greater than that of myocardial enzymes. Therefore can be used as early diagnostic markers of AMI.Because Myo is also present in skeletal muscle and is only cleared from the kidney, Myo is elevated in patients with acute muscle injury, acute or chronic renal failure, severe congestive heart failure, prolonged shock and myopathy caused by various reasons, intramuscular injection, strenuous exercise, and ingestion of certain toxins and drugs.Therefore, the determination of serum Myo level must be combined with other aspects of patient evaluation to assist in the diagnosis of AMI.
Test Principle
Double antibody sandwich method was used in the kit. The detection principle is: the sample to be tested, R1 reagent, R2 reagent and M reagent are mixed for incubation, and the fluorescein (FITC) labeled Myo antibody 1 in R1 reagent and the alkaline phosphatase (ALP) labeled Myo antibody 2 in R2 reagent are combined with the Myo antigen molecules in the sample to form an immune complex. The immune complex is further captured by anti-FITC antibodies coupled to the surface of the magnetic particle and adsorbed to the surface of the magnetic particle. After washing, the unbound material was removed and the luminescent substrate was added, ALP catalyzed the luminescence of the substrate, and the relative luminescence intensity (RLU) was determined.
| Product Parameter |
| Specimen |
Serum/Plasma |
| Detection range |
21-3000(ng/mL) |
| Precision |
CV<5% |
| Test Time |
15 Min |
| LOD |
21ng/mL |
Certificate
Applicable Device
Automated Chemiluminescence Immunoassay Analyzer CLite-160i
Biochip Langdao (Tianjin)Medical Technology Ltd. is a R&D based biotechnology company, specializing in the research and production of in vitro diagnostics, medical devices, and medical products for public health. "Biochip Langdao" has been awarded National High-tech Enterprise by the Chinese government, products are widely used in hospital laboratories, independent medical laboratories, physical examination centers, clinics, and pharmacies. Its holding company Beijing Promed Medical Technology Co.,Ltd. is a public company listed at BSE (Ticker: 835373).
"Biochip Langdao" owns Magnetic microparticle chemiluminescence technology, and has developed a patented strip-based fully automatic chemiluminescence immunoassay analyzer: CLite-160i analyzer. 12 testing reagents have been successfully developed on CLite-160i analyzer including 5 myocardial biomarkers, 4 inflammatory biomarkers, and 3 gastritis markers, all of which have obtained NMPA and CE certificate. More testing reagents are in R&D pipeline and are expected to launch by March 31, 2024, including thyroid hormones, sex hormones, tumor markers, brain injury, acute renal disfunction.
In addition, the company has established production lines for sprays, powders, gel, and granules medical products. These include medical equipment, disinfectant, personal care products. Among them, "Well-Fit" Anti-allergy nasal barrier gel is unique in this field which has a special formula and unique dosage form, indicated to use for prevention and treatment of allergic rhinitis and prevention of flu.
The company owns the registered trademark "Biochip Langdao" covering fields such as in vitro diagnostics, medical devices, and biological preparations, and the registered trademark "Well-Fit" covering fields such as oral and nasal medication, disinfectant, and medical dressings.
"Biochip Langdao" adheres to its business philosophy of "Developing by Innovation, Integrity as Cornerstone", keeps investing for more advanced technology and improving products quality.
Office
Lab
Workshop
Logistics
FAQ
1.How to ship the product?
The shipping way normally depends on your quantity,total CBM and weight.
We have our own shipping company to provide best shipping cost and efficient way.
2. Do you provide samples? Is it free or extra?
Yes, if you buy equipment we could offer a sample test for free charge but do not pay the cost of freight.
3.what can you buy from us?
Chemiluminescence Immunoassay Analyzer,In Vitro Diagnostic Reagent ,Healthy Care etc.
4. What is your warranty?
For most products the warranty is for 12 months, for some products we provide 18 months warranty.
5.Do you have the CE certificate ?
Yes, most of our products have the CE certificate.
Audited Supplier 
Audited Supplier 
){kind=link}
){kind=link}